2025 was a year defined by momentum, across science, data, and the rapidly evolving ecosystems that enable modern R&D. Organizations around the world continued to push for greater connectivity, smarter workflows, and more unified scientific environments. And as we look back, one trend becomes unmistakably clear: the move toward integrated, insight-ready solutions is no longer aspirational; it’s becoming the global baseline.
Within this broader shift, India’s expanding digital infrastructure, deep scientific talent, and growing appetite for AI-enabled solutions placed it firmly within the global conversation about what modern innovation looks like.
At the same time, the patterns playing out across India reflected a broader global reality: scientists everywhere are demanding tools that connect disciplines, simplify decision-making, and unlock the value of their data. 2025 showcased a decisive shift toward solutions, workflows, and insights that scale effortlessly across teams and time zones.
With this context, the milestones we achieved throughout the year take on even greater significance. Below, we revisit the global advances, customer collaborations, and product innovations that defined Revvity Signals in 2025. We explore how they tie into the evolving India market and set the stage for what’s possible in 2026.
Celebrating 40 Years of ChemDraw ™
ChemDraw’s 40th anniversary reminded us how standardization unlocks scale: precise, machine-readable structures are now fuel for ML models and semantic search in Indian labs as much as anywhere else. Today’s Signals ChemDraw ™ extends that tradition with cloud collaboration and modeling, a familiar toolset for India’s large chemistry education base and growing materials programs.
Unifying Data to Accelerate Discovery
At Bio-IT World, we launched Signals One™, a cloud-native solution that spans the “Design-Make-Test-Decide” lifecycle and standardizes experimental data to be AI-ready. For India’s multi-domain teams (pharma, biopharma, materials, specialty chemicals), this matters: unified, interoperable data lowers adoption barriers and reduces manual wrangling across silos.
Continuous Innovation to Meet Evolving Needs
In 2025, we laid out our intent to expand our capabilities through targeted acquisition and new to market solutions. We announced our plans to integrate ACD/Labs technologies into the Revvity Signals platform, a move that will deliver a unified SaaS environment for customers across pharmaceuticals and material sciences. We also previewed Signals BioDesign for streamlined molecular biology, Signals LabGistics for end-to-end workflow management, and introduced Signals Xynthetica™ (Models-as-a-Service) to augment molecular and materials design.
In today’s rapidly evolving scientific landscape, innovation is essential. If solutions fail to advance alongside the needs of scientists, they risk becoming obsolete as the market continues to move forward.
Customer Collaboration & Community
Customer partnerships continued to be a defining strength of Revvity Signals in 2025, shaping not only the evolution of our solutions but also the ways scientific teams collaborate and scale insight across disciplines.
In 2025 we shipped 17% of submitted ideas, nearly double the industry’s average clearance rate of 10%, demonstrating our commitment to turning customer insights into real-world solutions. Along with the increased guidance we got through the Ideas portal, we shaped the roadmap for 2025 around customer support, feedback, and highlights through virtual and live events across the globe such as NEXUS India.
First launched in 2018, NEXUS India has become one of our most engaging forums, designed as a space for customers to come together, share best practices, and exchange insights. This successful event program will continue in future years, expanding opportunities for customers to contribute, learn from peers, and influence the direction of scientific digitalization across the region, all whilst focusing specifically on the challenges within the India market and how Indian customers have overcome these.
AI Momentum in 2025
India’s AI landscape is evolving rapidly. Under the IndiaAI Mission, the government is investing in indigenous models, national-scale datasets, and a planned 38,000+ GPU compute backbone over five years, designed to expand applied AI capacity across sectors including pharma, BFSI, manufacturing, and public services.
This nationwide push toward high-performance compute and domain-specific AI is creating an environment where capabilities such as semantic search, text-to-image insight extraction, and retrieval-augmented decision support, as delivered in Signals One and Signals Clinical, can be adopted more quickly and more broadly. As India’s talent base and digital ecosystems scale, global AI advancements are being translated into fast, practical deployments in scientific and clinical workflows.
Looking ahead to 2026: India as a growth amplifier
As we look ahead to 2026, Revvity Signals will continue to strengthen the connections that defined 2025, advance platform capabilities across research and clinical domains, expand AI where it delivers meaningful value, and deepen customer collaboration through the Ideas Portal and collaborative consortia and events.
Partnerships with technology providers and model developers will bring more domain-specific intelligence into context, while customer education initiatives will empower teams to apply these innovations with confidence.
India’s unique blend of digital infrastructure, fast-moving AI investment, and rapidly advancing scientific capabilities positions the country as one of the most powerful environments for turning connected data into meaningful scientific outcomes.
For Revvity Signals, 2026 will be a year of continued unity across data and tools, and importantly with the global scientific community we support and innovate for.
